arrow
A

Atsushi Oba

cancer institute hospital
H指数:24
被引数:2,123

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Expert Survey on Chyle Leakage After Pancreaticoduodenectomy: The Precision Anatomy for Minimally Invasive Hepato-Biliary-Pancreatic Surgery (PAM-HBP Surgery) Project 2024

胰腺十二指肠切除术后乳糜漏的专家调查:微创肝胆胰手术精准解剖(PAM-HBP Surgery)项目2024

2026-05-250
PRE
Global Survey of Technical Preferences for Robotic Versus Laparoscopic Segmentectomy of Liver Segments 7 and 8: A 2024 PAM-HBP Surgery Project

全球范围内对于肝段7和8机器人与腹腔镜段切除术的技术偏好调查:一项2024年PAM-HBP手术项目

2026-05-200
PRE
Incisional hernia after inverted L-shaped incision in open hepatectomy: A topographical analysis and comparison of 2 fascial closure methods

开腹肝切除术倒 L 形切口后切口疝:解剖学分析及 2 种筋膜闭合方法的比较

Surgery
IF2.7
2026-05-110
PRE
Survival Impact After Resection for Postoperative Recurrence or Metastasis of Pancreatic Ductal Adenocarcinoma Analyzed Using a Time-Dependent Cox Regression Model

胰腺导管腺癌术后复发或转移切除后的生存影响:基于时间依赖性Cox回归模型的分析

2026-01-010
PRE
Staging laparoscopy to detect occult metastases in localized pancreatic cancer: global survey among nine international societies

局部胰腺癌中用于检测隐匿性转移的分期腹腔镜:九个国际学会的全球调查

HPB
IF2.4
2025-12-060
OAAI
ASO Visual Abstract: Favorable Response Defined by CA19-9 Reduction After Neoadjuvant Treatment for Pancreatic Cancer

ASO视觉摘要:胰腺癌新辅助治疗后以CA19-9下降定义的良好应答

2025-09-020
PRE
Favorable Response Defined by CA19-9 Reduction After Neoadjuvant Treatment for Pancreatic Cancer

以CA19-9降低定义的胰腺癌新辅助治疗后的良好反应

2025-09-010
PRE